Potent and selective G9a/GLP histone lysine methyltransferase inhibitor (IC50
= 3.3 nM). Exhibits >1000-fold selectivity for G9a/GLP over 21 other methyltransferases. Decreases levels of lysine 9 dimethylation on histone H3 (H3K9Me2) in PC3 cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
This probe is supplied in conjunction with the Structural Genomics Consortium. For further characterization details, please visit the A 366 probe summary
on the SGC website.
Discovery and development of potent and selective inhibitors of histone methyltransferase G9a.
Sweis et al.
ACS Med.Chem.Lett., 2014;5:205